Sector Chart Finch Therapeutics Group, Inc.

Stocks

FNCHQ

US31773D2009

Biotechnology & Medical Research

Market Closed - OTC Markets 19:29:54 17/08/2026 +03			5-day change	1st Jan Change
10.20 ^USD	+0.99%		+0.49%	-24.37%

04-27	Acurx Pharmaceuticals, Inc., Adiso Therapeutics, Inc., Summit Therapeutics Inc., Finch Therapeutics Group, Inc. and Astrazeneca plc Announces Clostridium Difficile Infections Clinical Trial Updates	CI
03-26	Motion for Joint Administration Approved for Finch Therapeutics Group, Inc.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
FINCH THERAPEUTICS GROUP, INC.	16.38M	-	-	-	-	-
LONZA GROUP AG	48.84B
REVOLUTION MEDICINES, INC.	45.44B	-	-	-	-	-
BEONE MEDICINES AG	41.22B
IQVIA HOLDINGS INC.	39.71B
CELLTRION, INC.	32.6B